Literature DB >> 10983673

Fetal growth and blood pressure in a Danish population aged 31-51 years.

H T Sørensen1, A M Thulstrup, B Nørgdård, M Engberg, K M Madsen, S P Johnsen, J Olsen, T Lauritzen.   

Abstract

During the past decade, studies have shown an inverse association between birth weight and blood pressure and risk of coronary heart disease in adult life. From old public archives we were able to trace the birth records of 545 out of 905 persons (60.2%) aged 31-51 years who participated in the Ebeltoft Health Promotion Project in Denmark. We examined the associations between birth weight, length at birth, Ponderal Index and systolic and diastolic blood pressure. No associations were found for women. For men, the mean systolic blood pressure fell from 131.1 mmHg with a birth weight of less than 3300 g to 129.6 mmHg with a birth weight of more than 4000 g, and for diastolic blood pressure 81.6 mmHg to 80.3 mmHg, respectively. For men, the mean systolic blood pressure fell from 135.7 mm Hg with a birth length of 30-51 cm to 131.6 with a birth length of 55-62 cm, and for diastolic blood pressure 83.0 mmHg to 78.8 mmHg, respectively. The associations may reflect organ programming in fetal life.

Entities:  

Mesh:

Year:  2000        PMID: 10983673     DOI: 10.1080/14017430050196216

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  2 in total

1.  Fatness at birth predicts adult susceptibility to ovarian suppression: an empirical test of the Predictive Adaptive Response hypothesis.

Authors:  Grazyna Jasienska; Inger Thune; Peter T Ellison
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

2.  Peroxisome proliferator-activated receptor-gamma agonist improves skeletal muscle insulin signaling in the pregestational intrauterine growth-restricted rat offspring.

Authors:  Shilpa Oak; Cang Tran; Maria-Olivia Castillo; Shanthie Thamotharan; Manikkavasagar Thamotharan; Sherin U Devaskar
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-02       Impact factor: 4.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.